OMI Urges Appeals Court to Allow Antitrust Challenge to Amgen's Extension of Enbrel Monopoly
August 14, 2026
August 14, 2026
WASHINGTON, Aug. 14 [Category: Business] -- Open Markets Institute posted the following news release:
* * *
OMI Urges Appeals Court to Allow Antitrust Challenge to Amgen's Extension of Enbrel Monopoly
*
Read The Brief
#Amicus brief argues monopolists cannot use acquisitions of pending patents to shut out rivals and keep drug prices high
The Open Markets Institute filed an amicus brief in the U.S. Court of Appeals . . .
* * *
OMI Urges Appeals Court to Allow Antitrust Challenge to Amgen's Extension of Enbrel Monopoly
*
Read The Brief
#Amicus brief argues monopolists cannot use acquisitions of pending patents to shut out rivals and keep drug prices high
The Open Markets Institute filed an amicus brief in the U.S. Court of Appeals . . .